Letter: PCSK9 inhibitor for liver transplant patients during the post‐statin era? Authors' reply

Autor:	Chiara Becchetti, Melisa Dirchwolf, Annalisa Berzigotti, Jaume Bosch
Rok vydání:	2022
Předmět:	Hepatology Gastroenterology Humans Pharmacology (medical) Hydroxymethylglutaryl-CoA Reductase Inhibitors Proprotein Convertase 9 Antiviral Agents Liver Transplantation
Zdroj:	Alimentary Pharmacology & Therapeutics. 57:187-188
ISSN:	1365-2036 0269-2813
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c849c2cb5f59610db40e389f1a97cfdf https://doi.org/10.1111/apt.17295 Zobrazit plný text záznamu Plný text